COO · Cooper Companies, Inc. · Earnings Call Transcripts & Audio
$56.53
-0.10 (-0.18%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$10.86B
Shares
190.16M
Volume · Sep 30
4.9M
Avg daily vol (3M)
3.05M
Cooper Companies, Inc. Earnings Call Transcripts
Quarterly earnings calls for Cooper Companies, Inc. (COO), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲11.7%
$848.00M
$65.50M
'22 Q4
22-12-08
▲9.1%
$858.50M
$84.60M
'23 Q1
23-03-02
▲5.7%
$877.40M
$39.80M
'23 Q2
23-06-01
▲10.3%
$930.20M
$85.30M
'23 Q3
23-08-30
▲9.3%
$927.10M
$84.50M
'23 Q4
23-12-07
▲8.5%
$931.60M
$81.20M
'24 Q1
24-02-29
▲7.4%
$942.60M
$88.90M
'24 Q2
24-05-30
▲7.8%
$1.00B
$104.70M
'24 Q3
24-08-28
▲9.8%
$1.02B
$117.50M
'24 Q4
24-12-05
▲3.6%
$964.70M
$104.30M
'25 Q1
25-03-06
▲6.3%
$1.00B
$87.70M
'25 Q2
25-05-29
▲5.7%
$1.06B
$98.30M
'25 Q3
25-08-27
▲4.6%
$1.07B
$84.60M
'25 Q4
25-12-04
▲6.2%
$1.02B
$130.80M
'26 Q1
26-03-05
▲7.9%
$1.08B
−$77.90M
'26 Q2
26-06-04
LATEST
▲0.6%
$1.07B
$432.80M
'26 Q3
26-09-09
Earnings call
FY26 · Q3
2026-09-09
Cooper Companies, Inc. (COO) Q3 2026 Earnings Call Transcript
Positive tone
Sales force expansion
Cooper Surgical (CSI) portfolio review
EMR&D market contrast
Revenue
$1.07B
▲ 0.6% YoY Diluted EPS
$2.24
▲ 357.1% YoY Gross margin
66.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-06-04
Cooper Companies, Inc. (COO) Q2 2026 Earnings Call Transcript
Confident tone
Asia-Pacific Headwinds
Cooper Vision / Americas & EMEA Growth
Myopia Control (MiSight)
Revenue
$1.08B
▲ 7.9% YoY Diluted EPS
$-0.40
▼ 190.9% YoY Gross margin
68.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-03-05
Cooper Companies, Inc. (COO) Q1 2026 Earnings Call Transcript
Confident tone
Raised guidance for earnings and free cash flow
CooperVision market share and premium product growth
Asia Pacific and Japan softness
Revenue
$1.02B
▲ 6.2% YoY Diluted EPS
$0.66
▲ 26.9% YoY Gross margin
67.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-12-04
Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript
Confident tone
CooperVision market share and MyDay momentum
Private label contract wins
Product launches and pipeline
Revenue
$1.07B*
▲ 4.6% YoY Gross margin
61.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-08-27
Cooper Companies, Inc. (COO) Q3 2025 Earnings Call Transcript
Positive tone
MyDay growth and rollout
Regional performance
Margin and earnings execution
Revenue
$1.06B
▲ 5.7% YoY Diluted EPS
$0.49
▼ 5.8% YoY Gross margin
65.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-05-29
Cooper Companies, Inc. (COO) Q2 2025 Earnings Call Transcript
Positive tone
CooperSurgical fertility softness, especially Asia Pac
CooperVision contact lens growth
Daily silicone hydrogel expansion and product launches
Revenue
$1.00B
▲ 6.3% YoY Diluted EPS
$0.44
▲ 0% YoY Gross margin
67.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-06
Cooper Companies, Inc. (COO) Q1 2025 Earnings Call Transcript
Confident tone
CooperVision product portfolio and launches
Margin and earnings performance
Capacity expansion
Revenue
$964.70M
▲ 3.6% YoY Diluted EPS
$0.52
▲ 26.8% YoY Gross margin
68.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-12-05
Cooper Companies, Inc. (COO) Q4 2024 Earnings Call Transcript
Confident tone
CooperVision Daily Silicone Hydrogel Growth (MyDay, clariti)
MiSight Myopia Management
Industry Shift to Dailies and Torics
Revenue
$1.02B*
▲ 9.8% YoY Gross margin
66.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-08-28
Cooper Companies, Inc. (COO) Q3 2024 Earnings Call Transcript
Confident tone
Daily Contact Lens Growth and Capacity Expansion
CooperSurgical Record Revenues
Myopia Management with MiSight
Revenue
$1.00B
▲ 7.8% YoY Diluted EPS
$0.52
▲ 20.9% YoY Gross margin
66.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-05-30
Cooper Companies, Inc. (COO) Q2 2024 Earnings Call Transcript
Confident tone
CooperSurgical and PARAGARD
Myopia Management with MiSight
China and Ortho-K Headwinds
Revenue
$942.60M
▲ 7.4% YoY Diluted EPS
$0.44
▲ 120% YoY Gross margin
67.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-02-29
Cooper Companies, Inc. (COO) Q1 2024 Earnings Call Transcript
Confident tone
MyDay Daily Silicone Hydrogel Portfolio
CooperSurgical and Fertility Business
Myopia Management and MiSight
Revenue
$931.60M
▲ 8.5% YoY Diluted EPS
$0.41
▼ 4.7% YoY Gross margin
67.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-07
Cooper Companies, Inc. (COO) Q4 2023 Earnings Call Transcript
Revenue
$927.10M*
▲ 9.3% YoY Gross margin
65.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-08-30
Cooper Companies, Inc. (COO) Q3 2023 Earnings Call Transcript
Revenue
$930.20M
▲ 10.3% YoY Diluted EPS
$0.43
▼ 13.1% YoY Gross margin
65.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-01
Cooper Companies, Inc. (COO) Q2 2023 Earnings Call Transcript
Revenue
$877.40M
▲ 5.7% YoY Diluted EPS
$0.20
▼ 68.6% YoY Gross margin
66.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-02
Cooper Companies, Inc. (COO) Q1 2023 Earnings Call Transcript
Revenue
$858.50M
▲ 9.1% YoY Diluted EPS
$0.43
▼ 9.9% YoY Gross margin
65.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-08
Cooper Companies, Inc. (COO) Q4 2022 Earnings Call Transcript
Revenue
$848.00M*
▲ 11.7% YoY Gross margin
63.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-08-31
Cooper Companies, Inc. (COO) Q3 2022 Earnings Call Transcript
Revenue
$843.40M
▲ 10.5% YoY Diluted EPS
$0.50
▼ 84% YoY Gross margin
65.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-02
Cooper Companies, Inc. (COO) Q2 2022 Earnings Call Transcript
Revenue
$829.80M
▲ 15.3% YoY Diluted EPS
$0.64
▲ 8.1% YoY Gross margin
64.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-03-03
Cooper Companies, Inc. (COO) Q1 2022 Earnings Call Transcript
Revenue
$787.20M
▲ 15.7% YoY Diluted EPS
$0.48
▼ 95.5% YoY Gross margin
65.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-12-02
Cooper Companies, Inc. (COO) Q4 2021 Earnings Call Transcript
Revenue
$759.10M*
▲ 11.4% YoY Gross margin
66.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-09-02
Cooper Companies, Inc. (COO) Q3 2021 Earnings Call Transcript
Revenue
$763.40M
▲ 32% YoY Diluted EPS
$3.09
▲ 1004.5% YoY Gross margin
67.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-06-03
Cooper Companies, Inc. (COO) Q2 2021 Earnings Call Transcript
Revenue
$719.50M
▲ 37.1% YoY Diluted EPS
$0.59
▲ 926.1% YoY Gross margin
67.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-03-04
Cooper Companies, Inc. (COO) Q1 2021 Earnings Call Transcript
Revenue
$680.50M
▲ 5.3% YoY Diluted EPS
$10.58
▲ 2224.7% YoY Gross margin
66.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-12-03
Cooper Companies, Inc. (COO) Q4 2020 Earnings Call Transcript
Revenue
$681.60M
▼ 1.4% YoY Diluted EPS
$0.41
▼ 32.2% YoY Gross margin
62.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-09-03
Cooper Companies, Inc. (COO) Q3 2020 Earnings Call Transcript
Revenue
$578.20M
▼ 14.9% YoY Diluted EPS
$0.28
▼ 53.3% YoY Gross margin
62.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-06-04
Cooper Companies, Inc. (COO) Q2 2020 Earnings Call Transcript
Revenue
$524.90M
▼ 19.8% YoY Diluted EPS
$0.06
▼ 90.6% YoY Gross margin
61.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-03-05
Cooper Companies, Inc. (COO) Q1 2020 Earnings Call Transcript
Revenue
$646.20M
▲ 2.9% YoY Diluted EPS
$0.46
▼ 12.1% YoY Gross margin
66.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–27 of 27 earnings calls
Key facts
CIK
711404
CUSIP
216648501
13F (30d)
18 filings
14 filers
Visit website
Investor relations